Financial Results (Consolidated and Standalone) for the quarter and financial year ended March 31, 2025.
MCX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.6 pts less than Nifty Midcap 150 and 4.0 pts less than its Capital Markets peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
MCX reported a sharp jump in FY25 earnings. Consolidated income from operations rose to ₹1,11,266 lakhs from ₹68,355 lakhs in FY24, a ~63% increase. Net profit after tax surged to ₹56,004 lakhs from ₹8,311 lakhs (~574% growth), translating to EPS of ₹109.82 vs ₹16.30. On a standalone basis, revenue grew to ₹1,01,158 lakhs (~70% YoY) and PAT jumped to ₹41,478 lakhs from ₹5,196 lakhs. Q4 FY25 PAT was ₹13,546 lakhs (consolidated), down sequentially from ₹16,004 lakhs in Q3. The Board recommended a final dividend of ₹30 per share (subject to AGM approval) and appointed M/s V Sankar Aiyar & Co as the new statutory auditor for 5 years, replacing Shah Gupta & Co, who issued an unmodified opinion on FY25 results. Operating cash flow more than doubled to ₹95,013 lakhs (consolidated).
The dramatic YoY profit growth reflects a rebound in commodity trading volumes and higher operating leverage, supporting a healthy dividend payout. The auditor change ahead of the AGM is a governance event worth noting but the clean (unmodified) audit opinion and strong cash generation are positives for shareholders.